FDA inspection
Changzhou Qianhong Biopharma Co., Ltd.: FDA inspection ending Oct 31, 2025
FDA inspection 1295032 · Voluntary Action Indicated (VAI) · Changzhou
Key facts
| Inspection ID | 1295032 |
|---|---|
| Firm | Changzhou Qianhong Biopharma Co., Ltd. |
| FEI number | 3005275502 |
| Address | 128 Xueye Road, Xuejiazhen Xinbei District |
| City | Changzhou |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Oct 31, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data